A strain of Nocardia interforma having low productivity of formycin A was selected. Washed cells of this strain convert formycin B to oxoformycin B (reaction I), while those of the original strain collected during formycin A producing phase convert formycin B to formycin A (reaction II). Reaction I is inhibited by allopurinol, an inhibitor of xanthine oxidase. Reaction II is inhibited by hadacidin, an inhibitor of adenylosuccinate synthetase, but not by B, a xanthosine analog of the formycin family, was first found in the urine of a rabbit injected with formycin A or formycin B4). Since oxoformycin B was proved to be biologically inert and no other metabolite appeared in the urine, this compound was assumed to be an end product by detoxication mechanism of the rabbit4). We observed recently that, in Nocardia interforma, formycin B was converted to formycin A as well as to oxoformycin B. In this connetion, studies were made to clarify the biochemical events which would be involved in these metabolic conversions and it was found that amination of formycin B to formycin A took place on the level of their phosphorylated forms, probably catalyzed by adenylosuccinate synthetase5). This amination process is likely to be involved in the biosynthesis of formycin A in Nocardia interforma.
METABOLIC CONVERSION OF FORMYCIN B TO FORMYCIN
A strain of Nocardia interforma having low productivity of formycin A was selected. Washed cells of this strain convert formycin B to oxoformycin B (reaction I), while those of the original strain collected during formycin A producing phase convert formycin B to formycin A (reaction II). Reaction I is inhibited by allopurinol, an inhibitor of xanthine oxidase. Reaction II is inhibited by hadacidin, an inhibitor of adenylosuccinate synthetase, but not by azaserine. As intermediates of reaction II, formycin B-monophosphate and formycin A-monophosphate were detected in the nucleotide pool of the cell. No other organisms than Nocardia interforma perform reaction II except Xanthomonas oryzae. Besides Nocardia interforma, Pseudomonas fluorescens and Streptomyces kasugaensis perform reaction I.
Formycin A and formycin B were isolated from the culture filtrate of Nocardia interforma1^ and identified as 7-amino-3-(/?-D-ribofuranosyl)pyrazolo [4,3-d] pyrimi dine and 3-(j9-D-ribofuranosyl)pyrazolo [4,3-d] 6(H)-7-pyrimidone, respectively^. They are analogs of adenosine and inosine with unusual C-riboside linkages. Oxoformycin B, a xanthosine analog of the formycin family, was first found in the urine of a rabbit injected with formycin A or formycin B4). Since oxoformycin B was proved to be biologically inert and no other metabolite appeared in the urine, this compound was assumed to be an end product by detoxication mechanism of the rabbit4). We observed recently that, in Nocardia interforma, formycin B was converted to formycin A as well as to oxoformycin B. In this connetion, studies were made to clarify the biochemical events which would be involved in these metabolic conversions and it was found that amination of formycin B to formycin A took place on the level of their phosphorylated forms, probably catalyzed by adenylosuccinate synthetase5). This amination process is likely to be involved in the biosynthesis of formycin A in Nocardia interforma.
Materials and Methods
Washed-cell suspension and reaction process : Cells of Nocardia interforma which had been grown under conditions for optimum production of formycin A1}, were collected at various days of growth. The cells were washed once in physiological saline by suspension and centrifugation, and the resulting cell-paste was suspended at 4 % (v/v) in 25ml of glucose-CzAPEK medium containing 1 mg of 3H-formycin B (5 juc)-Reaction proceeded at 27°C for 3 hours with reciprocal shaking and was terminated by chilling in an ice bath. The cells were separated from the medium by centrifugation, washed twice in physiological saline containing 10~4M of NaF (no NaF for Procedure II, see below) and submitted to analysis of labeled products which accumu lated in intracellular nucleotide pool (Procedure I). The medium and washings were combined and submitted to analysis of the labeled products which were released in the medium (Procedure II). No significant amount of labeled material other than 3H-formycin A, 3H-formycin B or 3H-oxoformycin B was detected in the medium under these conditions. Procedure I (identification of 3H-formycin A-monophosphate and 3H-formycin B-mono phosphate): The cells were extracted with 20ml of cold 10% perchloric acid and 20mlx2 of cold 5 % perchloric acid. The extracts were combined, neutralized with 10 % KOH and filtered.. The nitrate was charged on a charcoal (1g) column. After washing off unadsorbed ma terials with water, 50ml of ammoniacal ethanol 50 : 5 : 45) was passed through. The eluate was evaporated to dryness in vacuo, and the residue was dissolved in 4ml of water. The solution was charged onto a column of Dowex 1x4 (100^200 mesh, Cl" form, 3ml of wet volume). After washing off unadsorbed materials (mostly intracellular 3H-nucleosides) with water, nucleotides were eluted with 0.01 N HC1 0.02N NaCl. The eluate was again applied to a charcoal (500 mg) column to remove un adsorbed inorganic salts. The nucleotide fraction eluted with ammoniacal ethanol was concentrated in vacuo to 1 ml and analyzed by (a) paper chromatography developed with a solvent system of w-butanol-ethanol-water (50: 15: 35)6), (b) DEAE-cellulose paper chromatography developed with a solvent system of tert-amyl alcohol-formic acid-water (3:2:1)7) and (c) high voltage paper electrophoresis at 3,500 volt for 15 minutes in a buffer system of formic acid-acetic acid-water (25 : 75 : 900). Authentic preparations of formycin A-monophosphate and formycin B-monophosphate which were prepared by chemical or enzymatic processes as described in a previous paper8) were run as markers in each procedure. 3H-Analogs were localized by inspection of the paper under ultra violet light, appropriate areas were cut out and placed in counting vials, each of which contained 1 ml of water and 9 ml of scintillation mixture (PPO and naphthalene in dioxane),. and the radioactivity was determined in a Beckman Liquid Scintillation System. For con clusive identification, a fraction containing each 3H-nucleotide analog was treated with alkaline phosphatase (intestinal) to give the corresponding nucleoside whose identification procedure is given in Procedure II. Procedure II (identification of 3H-formycin A, 3H-formycin B and 3H-oxoformycin B) : The combined solution was charged onto a charcoal (1 g) column. After washing off unadsorbed materials with water, labeled products were eluted with 80ml of 50 % aqueous, acetone (pH8.0). The eluate was concentrated to 2ml, which was submitted to two analytical procedures : (a) 0.05ml was spotted onto a paper strip (Toyo Roshi, No. 51A) for analysis by high voltage paper electrophoresis and the radioactivity in appropriate fractions, was counted as stated above ; (b) the rest of the concentrated solution was charged onto a column of Dowex 50x2 (H+ type, 4ml of wet volume) and eluted thoroughly with water.
3H-Oxoformycin B appeared at the front followed by 3H-formycin B with satisfactory separation. 3H-Formycin A was eluted with 0.5N NH4OH. A suitable volume of each, fraction was analyzed for radioactivity. Since 3H-oxoformycin B is lacking in 3H at C-5 of the chromophore moiety, the rate of conversion to this compound on the basis of 3H recovery was corrected by a factor of 0.58 which had been empirically obtained by a preliminary experiment.
Results
Productivity of an antibiotic is generally reduced after repeated passages and showed poor production of formycin A. The strain re taining high productivity of formycin A is designated here as Strain (b). As shown in Table 1 , accumulation of formycin A by Strain (b) reached 112mcg/ml at the 6th day of culture while Strain (a) accumulated only 15mcg/ml at the 4th day of culture. When 3H-formycin B was exposed to washed cells of these two strains, the reac tion patterns as followed by 3H-radioactivity were different. As shown in Table 2 , the amination reaction, yielding formycin A, predominated in the metabolism of Strain (b) especially at the 5th day of the culture. It should be remembered that this strain showed the maximum rate of formycin A-production during the period from the 5th to the 6th day of the culture. In contrast, Strain (a) showed marked rates of oxidation, yielding oxoformycin B. Only limited rate of amination was observed with this strain throughout the cultivation. Such good correlation between the amina tion activity and the trend of formycin A-production, in respect to the type of antibiotic-producing strain as well as the time course phenomenon, led us to assume that metabolic processes which were responsible for the conversion of formycin B to formycin A should be involved in the de novo synthesis of formycin A. Table 3 , the amination reaction was effectively blocked by hadacidin, an inhibitor of this enzyme10), while azaserine, a glutamine antagonistll), was without effect.
For a better demonstration of this metabolic scheme, an attempt was made to detect formycin B-monophosphate and formycin A-monophosphate in the nu cleotide pool of the cell. Adenylosuccinate synthetase is one of the most vulnerable enzymes which are involved in the nucleic acid metabolism, and NaF was reported to inhibit it in a specific manner12). When the cells were labeled with 3H-formycin B in the presence of NaF and CuSO4, accumulation of 3H-formycin B-monophos phate in the nucleotide pool was evident while that of 3H-formycin A-monophos phate was limited, as shown in Fig. 1 (a) .
The rate of conversion of 3H-formycin B to 3H-formycin A was severely inhibited. CuSO4 was used because of its possible stimulation of some phosphorylating en zyme135. Another advantage in using NaF and CuSO4 in combination was that both of them were inhibitors of phosphatase and therefore could protect those phos phorylated intermediates from the attack of the enzyme. When NaF and CuSO4
were added to the system 60 minutes after the reaction was initiated, that is, after the conversion of 3H-formycin B to 8H-for mycin A was allowed to proceed to some extent, an appreciable amount of 3H-for mycin A-monophosphate as well as 3H
formycin B-monophosphate was detected, as shown in Fig. 1 (b) .
Oxidation of formycin B to oxofor mycin B was inhibited by allopurinol, 4-hydroxypyrazolo (3,4-d) To block the alternative pathway to for mycin A, hadacidin was added to each system at 40 mcg/ml which had caused no effect on this oxidation process.
assume that this reaction is catalyzed by xanthine oxidase which is an omnipresent enzyme with low substrate specificity. However, contradictory to such assumption, either hypoxanthine or xanthine which could compete for xanthine oxidase with for mycin B caused only a partial inhibition of this reaction even at 200mcg/ml. These results are shown in Table 4 . In addition, a purified preparation of xanthine oxidase (milk; Sigma Go. Ltd.) failed to oxidize formycin B. This observation is consistent with the recent report by Lettre et al.15 ) that 9-ribosyl purines did not serve as substrates for xanthine oxidase. To elucidate these questions, studies are in progress to isolate and identify the enzyme (or enzymes) responsible for oxidation of for mycinB.
A variety of organisms other than Nocardia interforma were examined for their metabolic activity on formycin B and the results are summarized in Table 5 . No organism converted formycin B to formycin A except Xanthomonas oryzae which had been reported to be slightly active16). It was interesting to find that several organisms were active in converting formycin B to oxoformycin B.
To prepare the cell suspensions of bacteria and actinomycetes, 2-day-old and 5-day-old cell mats on agar slants were used respectively. Other conditions were as given under Materials and Methods. * Previous observations.
Discussion
Formycin B is accumulated in the culture broth of Nocardia interforma after the formycin A-producing stage in parallel with concomitant decrease in formycin A content. Apparently formycin B is derived from formycin A by catalytic action of adenosine deaminase. Accordingly, the terminal steps of the biosynthetic route of formycin family should be as the following scheme.
(?) >å Formycin B-monophosphate >Formycin A-monophosphate > Formycin A >FormycinB >OxoformycinB Oxoformycin B seems to be an irreversible end product, since it was found stable to metabolism of various organisms including Nocardia interforma.
